Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Jianpixiaozhong Particles for MDR Membranous Nephropathy
NCT02610595Unknown
- Sponsor
- Shanghai University of Traditional Chinese Medicine
- Start
- Dec 2015
- Primary completion
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of Jianpixiaozhong in idiopathic membranous nephropathy (IMN), sponsored by Shanghai University of Traditional Chinese Medicine. Primary endpoint: Remission rate of 24 hours urinary protein quantitative at 3 months. Status: unknown.
02
Drugs
Jianpixiaozhong
03
Conditions
idiopathic membranous nephropathy (IMN)
Beyond the preview
Go deeper on NCT02610595.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02610595.